HaTay Pharmaceutical JSC

HaTay Pharmaceutical JSC Gross Margin

The Gross Margin of HaTay Pharmaceutical JSC (DHT.VN) as of Nov 2, 2026 is 10.54 %. In the previous year, Gross Margin was 10.17 % — a change of 3.60% (higher).

Gross Margin

10.54 %

YoY

3.60%

Last updated:

Gross Margin of HaTay Pharmaceutical JSC is 2024 10.54 % . Gross Margin of HaTay Pharmaceutical JSC was 2023 10.17 % . It decreases by 3.60% higher compared to the previous year.

For HaTay Pharmaceutical JSC, the gross margin of 10.5% is down versus 11.9% a few years ago.

The HaTay Pharmaceutical JSC Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2017
15.15 VND
Jan 1, 2018
14.15 VND
Jan 1, 2019
12.31 VND
Jan 1, 2020
11.91 VND
Jan 1, 2021
9.57 VND
Jan 1, 2022
10.19 VND
Jan 1, 2023
10.17 VND
Jan 1, 2024
10.54 VND
The HaTay Pharmaceutical JSC Gross Margin history
YEARGross MarginYoY
10.54 %+3.60%
10.17 %-0.21%
10.19 %+6.49%
9.57 %-19.67%
11.91 %-3.22%
12.31 %-13.00%
14.15 %-6.63%
15.15 %+1.06%
15.00 %-4.92%
15.77 %-0.67%
15.88 %+9,865.29%
0.16 %+14.60%
0.14 %-2.30%
0.14 %+1.66%
0.14 %+7.06%
0.13 %-4.93%
0.14 %+1.98%
0.13 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

HaTay Pharmaceutical JSC Stock analysis

What does HaTay Pharmaceutical JSC do? Ha Tay Pharmaceutical JSC generates revenue through the manufacturing, import, and export of pharmaceuticals, cosmetics, and medical equipment. The company sells its products via wholesale and retail channels, targeting healthcare providers, pharmacies, and consumers. It also engages in the production and trading of cosmetic products, supplemental food, and laboratory chemicals, alongside medical equipment and supplies. The firm completed the acquisition of a 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company in 2013, expanding its market presence in pharmaceuticals and medical equipment. The company operates in the pharmaceutical sector, serving healthcare institutions, retail pharmacies, and end consumers. Its revenue streams include the sale of drugs, cosmetics, medical equipment, and related supplies. Additional income comes from supermarket operations, real estate leasing, and vocational training services, though these are secondary to its core pharmaceutical business. Ha Tay Pharmaceutical JSC's primary customers are healthcare providers, pharmacies, and consumers purchasing pharmaceuticals, cosmetics, and medical equipment. The firm's product portfolio spans drugs, vaccines, cosmetic products, supplemental food, and laboratory chemicals, with a focus on manufacturing and trading. The acquisition of the 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company has strengthened its position in the medical equipment market. HaTay Pharmaceutical JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about HaTay Pharmaceutical JSC stock

Gross Margin of HaTay Pharmaceutical JSC is 10.54 % in 2024.

Gross Margin of HaTay Pharmaceutical JSC changed from 10.17 % to 10.54 %, representing a 3.60% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin HaTay Pharmaceutical JSC since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's HaTay Pharmaceutical JSC with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — HaTay Pharmaceutical JSC

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — HaTay Pharmaceutical JSC